Table 2.
Variables compared and genotype |
In vivo |
In vitro |
||||
---|---|---|---|---|---|---|
n | rs | P | n | rs | P | |
Circadian period vs. morningness-eveningness score | ||||||
All | 31 | −0.369 | 0.041 | 32 | −0.223 | 0.220 |
PER34/4 | 13 | −0.500 | 0.082 | 13 | −0.176 | 0.565 |
PER34/5 | 6 | −0.029 | 0.957 | 8 | −0.491 | 0.217 |
PER35/5 | 12 | −0.497 | 0.100 | 11 | −0.119 | 0.727 |
Circadian period vs. timing of melatonin onset relative to habitual bed time | ||||||
All | 31 | 0.420 | 0.019 | 30 | −0.203 | 0.281 |
PER34/4 | 13 | 0.367 | 0.218 | 12 | −0.102 | 0.752 |
PER34/5 | 6 | 0.371 | 0.469 | 7 | −0.433 | 0.333 |
PER35/5 | 12 | 0.509 | 0.091 | 11 | −0.124 | 0.717 |
In vivo period vs. in vitro period | ||||||
All | 28 | 0.024 | 0.903 | |||
PER34/4 | 12 | −0.282 | 0.375 | |||
PER34/5 | 6 | 0.160 | 0.827 | |||
PER35/5 | 10 | 0.404 | 0.247 |
Nonparametric correlations between in vivo and in vitro period and morningness-eveningness score, as well as timing of melatonin onset relative to habitual bedtime.